Clinical Trial Update: Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing oral posaconazole administered three times daily versus weekly high-dose amphotericin B lipid complex in patients with invasive fungal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Invasive Fungal Infections

Drugs mentioned

• Amphotericin B lipid complex (amphotericin B lipid complex)
• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Invasive Fungal Infections, Hematologic Malignancies | Phase 3 | Status: COMPLETED | Results posted: 2016-01-06